ACRO BIOMEDICAL CO., LTD.: 10-Q filed 2022-05-16

Name: ACRO BIOMEDICAL CO., LTD.: 10-Q filed 2022-05-16
Creator: ACRO BIOMEDICAL CO., LTD.

What ACRO BIOMEDICAL CO., LTD. reported in its quarterly report filed 2022-05-16 (fiscal Q1 2022): 23 published measures, 47 facts as tagged in accession 0001640334-22-001037.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-05-16
Fiscal period: fiscal Q1 2022
Accession: 0001640334-22-001037 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ACRO BIOMEDICAL CO., LTD. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-03-31	728,594	USD
At 2021-12-31	761,077	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-03-31	85,375	USD
At 2021-12-31	117,370	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-03-31	643,219	USD
At 2021-12-31	643,707	USD
At 2021-03-31	628,877	USD
At 2020-12-31	685,868	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	-3,928,797	USD	90
2021-01-01 to 2021-03-31	-59,494	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	262,132	USD	90
2021-01-01 to 2021-03-31	-8,380	USD	90

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	298,500	USD	90
2021-01-01 to 2021-03-31	99,500	USD	90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	288	USD	90
2021-01-01 to 2021-03-31	14,616	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-03-31	-11,865,279	USD
At 2021-12-31	-7,936,482	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	3,928,100	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	-3,928,588	USD	90
2021-01-01 to 2021-03-31	-56,991	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-03-31	680,018	USD
At 2021-12-31	706,415	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2022-03-31	65,990	USD
At 2021-12-31	91,651	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	4,005,088	USD	90
2021-01-01 to 2021-03-31	86,491	USD	90

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	76,500	USD	90
2021-01-01 to 2021-03-31	29,500	USD	90

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	222,000	USD	90
2021-01-01 to 2021-03-31	70,000	USD	90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	1,485,088	USD	90
2021-01-01 to 2021-03-31	86,491	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-03-31	60,042,000	shares
At 2021-12-31	60,042,000	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2022-03-31	32,293,739	USD
At 2021-12-31	32,293,530	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2022-03-31	44,346	USD
At 2021-12-31	50,432	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2022-03-31	44,346	USD
At 2021-12-31	50,432	USD

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	0	USD	90
2021-01-01 to 2021-03-31	0	USD	90

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	299,500	USD	90
2021-01-01 to 2021-03-31	0	USD	90

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-03-31	0	USD	90
2021-01-01 to 2021-03-31	70,000	USD	90

Inspect the source

Entity: ACRO BIOMEDICAL CO., LTD. / CIK 0001622996
Captured: 2026-09-19T11:19:47.057Z
SEC response SHA-256: b3abbbd950a9b9c0ba03d5604cc52c43ddb41d59ea263147bca632d90b36b6c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001622996.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))